Smith & Nephew plc (LON:SN)
1,033.50
+16.00 (1.57%)
Feb 21, 2025, 5:56 PM BST
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.83B USD in the half year ending June 29, 2024, with 8.73% growth. This brings the company's revenue in the last twelve months to $5.64B, up 5.48% year-over-year. In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.
Revenue (ttm)
$5.64B
Revenue Growth
+5.48%
P/S Ratio
2.02
Revenue / Employee
$305.77K
Employees
18,452
Market Cap
9.01B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Genus | 668.80M |
Oxford Nanopore Technologies | 167.75M |
Smith & Nephew News
- 2 days ago - Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC - GuruFocus
- 6 days ago - Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand - GlobeNewsWire
- 17 days ago - Martin Cobb's Top Picks: Saputo, Smith & Nephew and Electronic Arts - BNN Bloomberg
- 19 days ago - Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes - GlobeNewsWire
- 24 days ago - Smith & Nephew Getting No Credit For Self-Improvement Efforts - Seeking Alpha
- 5 weeks ago - Smith & Nephew (SNN) Stock Surges Amid Strong Financial Performance - GuruFocus
- 5 weeks ago - Smith & Nephew PLC (SNN) Receives Favorable Ratings for Advanced Wound Care Solutions - GuruFocus
- 5 weeks ago - Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention - GlobeNewsWire